30 Day Trial

Implanet 3Q15 Growth +42% vs. 3Q14

Share:

Implanet reported 3Q15 revenue of €1.69MM (~US $1.87MM), +42% from 3Q14, and YTD 2015 revenue of €4.99MM (~$5.52MM), +13% YTD14. 

In 3Q15, Spine revenue grew +101% YoY to ~$0.87MM, while Knee + Arthroscopy grew +14% to ~$1MM. 

Year to date, the company has sold 771 JAZZ spinal units in the U.S., 1,951 in France and 1,684 elsewhere for a total of 4,406 JAZZ units sold during 2015.

U.S. sales of ~$516.7MM accounted for 59% of 3Q15 revenue and grew +352% vs. 3Q14.

Source: Implanet